Denosumab
Amgen
['denosumab']
#asco22 #mlmasco - abcsg 18: adjuvant denosumab (60 mg q6m while on ai) improves 8-yr dfs and bmfs in post menopausal women with ebc. adiuvant denosumab is an alternative to bisphosphonates. 
"What we cannot speak about we must pass over in silence" (L. Wittgenstein)